Fig. 1

Cisplatin increased ROS concentration in TC28a2 cells. We measured ROS levels by using DCFH-DA after treatment with cisplatin administered at various gradient concentrations. Data are expressed as percentages of the level for the PBS-treated control group and as the mean ± SD (n = 4). *p < 0.05 compared with control